About

"Shonan Health Innovation Park (Shonan iPark) is Japan’s first science park originating from a pharmaceutical company. It was established in April 2018, when Takeda Pharmaceutical Company Limited opened its research facility to external organizations. Shonan iPark aims to bring together industry, government, and academia across a wide range of sectors and organizational sizes to accelerate health innovation. Today, approximately 220 companies and organizations—including those in pharmaceuticals, next-generation medicine, cellular agriculture, AI, and government—are based at the park, with around 3,500 people forming a life sciences ecosystem as of August 2026.
Industrial & Infrastructure Fund Investment Corporation(IIF) holds the trust beneficiary interests in the land and buildings. The facilities and community are operated by iPark Institute Co., Ltd., which succeeded Takeda’s Shonan iPark business.
Led by professionals with extensive expertise in the life sciences business, Shonan iPark is guided by its vision, “Producing Innovation.” It aims to create an environment where research can be accelerated and innovations can be successfully translated into real-world applications."

Facility Overview

Facility Name: Shonan Health Innovation Park
(Shonan iPark)

Address: 26-1, Muraoka Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan
Access Map

Phone Number: 0466-50-1830

Trust beneficiary Right Holder: Industrial & Infrastructure Fund Investment Corporation (IIF)

Management Company: iPark Institute Co., Ltd.

Logo

The six blue dots forming a wave above the word “iPark” represent the concept of open innovation that the wave of a newly born idea may be small at first but grows as it resonates.